Does NIVOLUMAB Cause Hepatitis? 930 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 930 reports of Hepatitis have been filed in association with NIVOLUMAB (OPDIVO). This represents 1.1% of all adverse event reports for NIVOLUMAB.
930
Reports of Hepatitis with NIVOLUMAB
1.1%
of all NIVOLUMAB reports
179
Deaths
447
Hospitalizations
How Dangerous Is Hepatitis From NIVOLUMAB?
Of the 930 reports, 179 (19.2%) resulted in death, 447 (48.1%) required hospitalization, and 106 (11.4%) were considered life-threatening.
Is Hepatitis Listed in the Official Label?
Yes, Hepatitis is listed as a known adverse reaction in the official FDA drug label for NIVOLUMAB.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Hepatitis?
METHOTREXATE (1,835)
ACETAMINOPHEN (1,450)
TOCILIZUMAB (1,184)
HYDROXYCHLOROQUINE (1,133)
ADALIMUMAB (1,096)
RITUXIMAB (1,017)
ETANERCEPT (1,013)
LEFLUNOMIDE (997)
PEMBROLIZUMAB (935)
ABATACEPT (902)
Which NIVOLUMAB Alternatives Have Lower Hepatitis Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE